UOC
EQHA

UBS O'Connor’s EQ Health Acquisition Corp. EQHA Stock Holding History

UBS O'Connor’s Portfolio EQHA Stock Details EQHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-237,054
Closed -$2.34M – 790
2022
Q3 		$2.34M Sell
237,054
-23,832
-9% -$235K 0.03% 570
2022
Q2 		$2.56M Buy
+260,886
New +$2.56M 0.03% 556
2022
Q1 		– Sell
-256,271
Closed -$2.49M – 650
2021
Q4 		$2.49M Buy
256,271
+6,873
+3% +$67K 0.02% 546
2021
Q3 		$2.44M Hold
249,398
– – 0.02% 498
2021
Q2 		$2.41M Sell
249,398
-150,587
-38% -$1.47M 0.02% 468
2021
Q1 		$3.87M Buy
+399,985
New +$3.88M 0.06% 327

Other funds holding EQHA

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

UBS O'Connor's EQHA Position: Q4 2022 in Review

UBS O'Connor sold out of EQ Health Acquisition Corp. (EQHA) in Q4 2022, closing a stake of 237,054 shares — an estimated $2.34M sold.

UBS O'Connor first reported a position in EQHA in Q1 2021 and held it in 6 quarters. The position peaked at $3.87M in Q1 2021. 4 funds tracked by Wall St. Rank hold EQHA as of Q4 2022.

  • UBS O'Connor reported no remaining EQ Health Acquisition Corp. position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 237,054 EQ Health Acquisition Corp. shares in Q4 2022, an estimated $2.34M.
  • UBS O'Connor first reported a position in EQ Health Acquisition Corp. in Q1 2021 and held it in 6 quarters.
  • UBS O'Connor's EQ Health Acquisition Corp. position peaked at $3.87M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.